Use of maximum standardized uptake value on fluorodeoxyglucose positron-emission tomography in predicting lymph node involvement in patients with primary non-small cell lung cancer

• Published in: Anticancer research Vol. 34; no. 2; pp. 805 - 810
• Main Authors: Muto, Jun, Hida, Yasuhiro, Kaga, Kichizo, Ohtaka, Kazuto, Okamoto, Shozo, Tamaki, Nagara, Nakada-Kubota, Reiko, Hirano, Satoshi, Matsui, Yoshiro
• Format: Journal Article
• Language: English
• Published: Greece 01.02.2014
• Subjects: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung - diagnostic imaging; Carcinoma, Non-Small-Cell Lung - metabolism; Carcinoma, Non-Small-Cell Lung - pathology; Female; Fluorodeoxyglucose F18 - pharmacokinetics; Humans; Lung Neoplasms - diagnostic imaging; Lung Neoplasms - metabolism; Lung Neoplasms - pathology; Lymph Nodes - diagnostic imaging; Lymph Nodes - metabolism; Lymph Nodes - pathology; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals - pharmacokinetics; Retrospective Studies; FDG-PET; non-small cell lung cancer; SUVmax; lymph node involvement

Surgical resection is a standard therapeutic approach for some cases of non-small cell lung cancer (NSCLC). Fluorodeoxyglucose positron-emission tomography (FDG-PET) is now widely used in clinical diagnosis and staging of various types of cancers, including NSCLC. We investigated whether the maximum...